Barry Ticho
CIK: 0001780088
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Stoke Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (70 total)
- Oct 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $26.16$27K - Sep 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct3.9K shares at avg. $30.51$120K - Sep 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.6K shares at avg. $31.06$50K - Aug 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct242 shares at avg. $32.47$8K - Aug 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct4.5K shares at avg. $32.01$145K - Aug 14, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct10K shares- - Aug 3, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.3K shares at avg. $29.45$37K - Aug 3, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct5.9K shares at avg. $28.95$171K - Jul 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct6.7K shares at avg. $32.62$219K - Jul 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct500 shares at avg. $33.27$17K - Jun 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $30.58$55K - May 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct2.2K shares at avg. $32.79$74K - Apr 1, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $32.66$60K - Mar 19, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $29.99$44K - Mar 19, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct1.4K shares at avg. $2.19$3K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct6.1K shares at avg. $31.28$191K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct103 shares at avg. $32.85$3K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct483 shares at avg. $31.79$15K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct3.6K shares at avg. $32.74$117K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct2.6K shares at avg. $33.38$86K - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct13.1K shares- - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct10.8K shares- - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct10K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
60K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,051 | $26.16 | $27,494 | Direct |
| Sep 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 3,945 | $30.51 | $120,370 | Direct |
| Sep 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,600 | $31.06 | $49,691 | Direct |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 242 | $32.47 | $7,857 | Direct |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 4,525 | $32.01 | $144,833 | Direct |
| Aug 14, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 10,000 | - | $0 | Direct |
| Aug 3, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,269 | $29.45 | $37,377 | Direct |
| Aug 3, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 5,907 | $28.95 | $171,008 | Direct |
| Jul 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 6,728 | $32.62 | $219,434 | Direct |
| Jul 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 500 | $33.27 | $16,634 | Direct |
| Jun 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,795 | $30.58 | $54,891 | Direct |
| May 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 2,243 | $32.79 | $73,548 | Direct |
| Apr 1, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,838 | $32.66 | $60,029 | Direct |
| Mar 19, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,461 | $29.99 | $43,815 | Direct |
| Mar 19, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 1,365 | $2.19 | $2,989 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 6,100 | $31.28 | $190,831 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 103 | $32.85 | $3,384 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 483 | $31.79 | $15,354 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 3,577 | $32.74 | $117,109 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 2,587 | $33.38 | $86,342 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 13,100 | - | $0 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 10,750 | - | $0 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 10,000 | - | $0 | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award(A) Employee Stock Option (Right to Buy) | 60,000 | - | - | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award(A) Restricted Stock Units | 40,000 | - | - | Direct |
1-25 of 70 transactions
About Ticho Barry
Ticho Barry (SEC CIK 0001780088) files insider reports with the SEC as CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc. (STOK).
Signal8 holds 31 ownership filings by Ticho Barry, all Form 4s, filed between Sep 5, 2024 and Oct 2, 2026. Those filings report 70 transactions, from Sep 3, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ticho Barry's filings is in BEDFORD, MA.
Recent filings by Ticho Barry
- Oct 1, 2026: Open-market sale of STOK shares (Form 4, code S).
- Sep 1, 2026: Open-market sales of STOK shares (2 lines, Form 4, code S).
- Aug 18, 2026: Open-market sales of STOK shares (2 lines, Form 4, code S).
- Aug 14, 2026: Option exercise of STOK shares (Form 4, code M).
- Aug 3, 2026: Open-market sales of STOK shares (2 lines, Form 4, code S).
Other insiders filing for Stoke Therapeutics, Inc. (STOK)
- Allan Jonathan, GENERAL COUNSEL & CORP SEC
- Cumbo Alexander, Director
- Kaye Edward M. MD, Director
- Harrison Seth Loring, Director
- McCauley Thomas, Chief Scientific Officer
- TZIANABOS ARTHUR, Director